Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study

Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study

Abstract Background Anticholinergic medications are drugs that block cholinergic transmission, either as their primary therapeutic action or as a secondary effect. Patients with dementia may be particularly sensitive to the central effects of anticholinergic drugs. Anticholinergics also antagonise t...

Full description

Bibliographic Details
Main Authors: Annabelle Hook, Jessica L. Randall, Carla M. Grubb, Natalie Ellis, Jack Wellington, Aayushi Hemmad, Agisilaos Zerdelis, Andrew R. D. Winnett, Benjamin D. W. Geers, Bethany Sykes, Charlotte N. Auty, Cecilia Vinchenzo, Christiane E. Thorburn, Daniella Asogbon, Emily Granger, Heather Boagey, Juliet Raphael, Kajal Patel, Kartik Bhargava, Mary-Kate M. Dolley, Matthew J. Maden, Mehdin M. Shah, Qao M. Lee, Ratnaraj Vaidya, Simran Sehdev, Sneha Barai, Sophie Roche, Uzair Khalid, David A. Codling, Judith R. Harrison
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Geriatrics
Subjects:
Dementia
Alzheimer disease
Cholinesterase inhibitors
Muscarinic antagonists
Antidepressive agents
Antipsychotic agents
Online Access:https://doi.org/10.1186/s12877-022-03235-9

Internet

https://doi.org/10.1186/s12877-022-03235-9

Similar Items